Precision Medicine in Low- and Middle-Income Countries.
Precision Medicine in Low- and Middle-Income Countries.
复制标题
DOI:
10.1146/annurev-pathol-042320-034052
复制
发表时间:
2022-01-24
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Most cancer cases occur in low- and middle-income countries (LMICs). The sophisticated technical and human infrastructure needed for optimal diagnosis, treatment, and monitoring of cancers is difficult enough in affluent countries; it is especially challenging in LMICs. In Western, educated, industrial, rich, democratic countries, there is a growing emphasis on and success with precision medicine, whereby targeted therapy is directed at cancers based on the specific genetic lesions in the cancer. Can such precision approaches be delivered in LMICs? We offer some examples of novel partnerships and creative solutions that suggest that precision medicine may be possible in LMICs given heavy doses of will, creativity, and persistence and a little luck.
登录
查看更多内容
影响因子:
3.8
作者:
DeSantis, Carol E.;Bray, Freddie;Jemal, Ahmedin
通讯作者:
Jemal, Ahmedin
影响因子:
3.7
作者:
Bird, P. A.;Hill, A. G.;Houssami, N.
通讯作者:
Houssami, N.
影响因子:
4.1
作者:
Jobbagy, Zsolt;van Atta, Reuel;Gocke, Christopher D.
通讯作者:
Gocke, Christopher D.
影响因子:
168.9
作者:
Horwitz, Steven;O'Connor, Owen A.;Zinzan, Pier Luigi
通讯作者:
Zinzan, Pier Luigi
影响因子:
4.7
作者:
Drake TM;Knight SR;Harrison EM;Søreide K
通讯作者:
Søreide K